Federated Kaufmann Fund
33
271M
31
0.06
22
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 7 participants. Despite the Federated Kaufmann Fund, startups are often financed by Sutter Hill Ventures, Topspin Partners, Three Arch Partners. The meaningful sponsors for the fund in investment in the same round are Windamere Venture Partners, St. Paul Venture Capital, Section 32. In the next rounds fund is usually obtained by Warburg Pincus, St. Paul Venture Capital, RWI Group.
The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Alector, Dexcom, Cytokinetics, Inc.. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biopharma, Enterprise Software.
This Federated Kaufmann Fund works on 71 percentage points more the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. The top amount of exits for fund were in 2005. The common things for fund are deals in the range of 50 - 100 millions dollars.
Investments analytics
Analytics
- Total investments
- 33
- Lead investments
- 0
- Exits
- 22
- Follow on index
- 0.06
- Investments by industry
- Biotechnology (20)
- Health Care (14)
- Therapeutics (10)
- Pharmaceutical (7)
- Medical (7) Show 43 more
- Investments by region
-
- United States (27)
- United Kingdom (1)
- Switzerland (2)
- Latvia (1)
- Canada (1)
- Peak activity year
- 2021
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 3
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 152M
- Group Appearance index
- 0.97
- Avg. company exit year
- 8
- Avg. multiplicator
- 0.99
- Strategy success index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Laronde | 30 Aug 2021 | Biotechnology, Medical, Therapeutics | Early Stage Venture | 440M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.